MARVELL TECHNOLOGY GROUP LTD FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

Edgar Glimpses |

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual General Meeting of Shareholders held on July 1, 2014 (the "Annual Meeting") for Marvell Technology Group Ltd. (the "Company"), shareholders voted on the matters as set forth below. Each issued common share was entitled to one vote on the proposals voted on at the meeting.

1. The nominees for election to the Board were elected, each for a one-year term

until the 2015 annual general meeting of shareholders, based upon the following votes: Broker For Against Abstain Non-Votes Dr. Sehat Sutardja 329,960,359 12,215,946 7,409,071 88,938,523 Dr. Juergen Gromer 330,599,054 14,254,732 4,731,590 88,938,523 Dr. John G. Kassakian 330,484,020 14,224,817 4,876,539 88,938,523 Arturo Krueger 327,791,594 17,058,526 4,735,256 88,938,523 Dr. Randhir Thakur 330,606,470 14,257,227 4,721,679 88,938,523

With respect to the election of each director in the table above, an "abstain" vote had the same effect as an "against" vote.

2. The proposal to approve, on an advisory and non-binding basis, the compensation of the Company's named executive officers, was approved based upon the following votes: For 208,319,583 Against 138,365,306 Abstain 2,900,487 Broker Non-Votes 88,938,523 3. The proposal to re-appoint PricewaterhouseCoopers LLP as the Company's auditors and independent registered public accounting firm, and to authorize the audit committee, acting on behalf of the Board, to fix the remuneration of the auditors and independent registered public accounting firm, in both cases for the Company's fiscal year ending January 31, 2015, was approved based upon the following votes: For 431,051,230 Against 2,579,773 Abstain 4,892,896

--------------------------------------------------------------------------------

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ARVNF Arvind Ltd Global Dep Rcpt Shs n/a n/a n/a 0

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…